Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid. Grant

Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid. .

date/time interval

  • July 1, 2020 - May 31, 2023

awarded by

administered by

sponsor award ID

  • 1175R01DA052271-04
  • 7R01DA052271-01

contributor